candesartan has been researched along with Heart Failure, Systolic in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Heart Failure, Systolic: Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan cilexetil is a nonpeptide selective blocker of the angiotensin II receptor sub-type 1." | 6.43 | Candesartan in heart failure. ( Chonlahan, JS; Germany, RE; Ripley, TL, 2006) |
| "Candesartan cilexetil is a nonpeptide selective blocker of the angiotensin II receptor sub-type 1." | 2.43 | Candesartan in heart failure. ( Chonlahan, JS; Germany, RE; Ripley, TL, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ripley, TL | 1 |
| Chonlahan, JS | 1 |
| Germany, RE | 1 |
1 review available for candesartan and Heart Failure, Systolic
| Article | Year |
|---|---|
Candesartan in heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Death, Sudden; Heart Fa | 2006 |